Competitive endogenous network of circRNA, lncRNA, and miRNA in osteosarcoma chemoresistance
Open Access
- 16 September 2023
- journal article
- review article
- Published by Springer Nature in European Journal of Medical Research
- Vol. 28 (1) , 1-9
Abstract
Osteosarcoma is the most prevalent and fatal type of bone tumor. Despite advancements in the treatment of other cancers, overall survival rates for patients with osteosarcoma have stagnated over the past four decades Multiple-drug resistance—the capacity of cancer cells to become simultaneously resistant to multiple drugs—remains a significant obstacle to effective chemotherapy. The recent studies have shown that noncoding RNAs can regulate the expression of target genes. It has been proposed that “competing endogenous RNA” activity forms a large-scale regulatory network across the transcriptome, playing important roles in pathological conditions such as cancer. Numerous studies have highlighted that circular RNAs (circRNAs) and long noncoding RNAs (lncRNAs) can bind to microRNA (miRNA) sites as competitive endogenous RNAs, thereby affecting and regulating the expression of mRNAs and target genes. These circRNA/lncRNA-associated competitive endogenous RNAs are hypothesized to play significant roles in cancer initiation and progression. Noncoding RNAs (ncRNAs) play an important role in tumor resistance to chemotherapy. However, the molecular mechanisms of the lncRNA/circRNA-miRNA-mRNA competitive endogenous RNA network in drug resistance of osteosarcoma remain unclear. An in-depth study of the molecular mechanisms of drug resistance in osteosarcoma and the elucidation of effective intervention targets are of great significance for improving the overall recovery of patients with osteosarcoma. This review focuses on the molecular mechanisms underlying chemotherapy resistance in osteosarcoma in circRNA-, lncRNA-, and miRNA-mediated competitive endogenous networks.Keywords
Funding Information
- Natural Science Foundation of Shanghai Municipality (22ZR1456600)
- Fundamental Research Funds for the Central Universities (22120210567)
- science and technology innovation action plan in shanghai on experimental animal research (22140903600)
This publication has 66 references indexed in Scilit:
- Expression Patterns of Circular RNAs from Primary Kinase Transcripts in the Mammary Glands of Lactating RatsJournal of Breast Cancer, 2015
- Therapeutic potential of siRNA and DNAzymes in cancerTumor Biology, 2014
- Inhibition of the Wnt-β-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapyBiochemical and Biophysical Research Communications, 2013
- A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?Cell, 2011
- OsteosarcomaAnnals of Oncology, 2010
- Chemotherapy resistance in osteosarcoma: current challenges and future directionsExpert Review of Anticancer Therapy, 2006
- Surgical options and outcomes in bone sarcomaExpert Review of Anticancer Therapy, 2006
- Primary Metastatic Osteosarcoma: Presentation and Outcome of Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group ProtocolsJournal of Clinical Oncology, 2003
- Ewing TumourPediatric Drugs, 2001
- Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures.Proceedings of the National Academy of Sciences, 1976